Close
Publication: CCTU colleagues published in the Lancet
7 October 2017
"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial"
Our colleague Kate Maclagan, Kashfia Chowdhury and Steve Hibbert from the EXENATIDE-PD3 trial has been published in the Lancet.
The paper is available to read via the National Library of Medicine website here: https://pubmed.ncbi.nlm.nih.gov/28781108